BackTable / Urology / Podcast / Episode #264

Contemporary Diagnostics in NMIBC: Clinical Insights

with Dr. Anne Schuckman and Dr. Piyush Agarwal

How are leading urologic oncologists using advanced biomarkers and artificial intelligence to refine the diagnosis and management of non-muscle invasive bladder cancer (NMIBC)? In the opening episode of our 2025 NMIBC Creator Weekend™ series, host Dr. Bogdana Schmidt engages in an insightful, in-studio discussion with Dr. Anne Schuckman and Dr. Piyush Agarwal about contemporary strategies and challenges in the diagnosis of non-muscle invasive bladder cancer.

This podcast is supported by:

Ferring Pharmaceuticals

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Contemporary Diagnostics in NMIBC: Clinical Insights with Dr. Anne Schuckman and Dr. Piyush Agarwal on the BackTable Urology Podcast

Ep 264 Contemporary Diagnostics in NMIBC: Clinical Insights with Dr. Anne Schuckman and Dr. Piyush Agarwal

00:00 / 01:04

BackTable, LLC (Producer). (2025, October 10). Ep. 264 – Contemporary Diagnostics in NMIBC: Clinical Insights [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Piyush Agarwal

Dr. Piyush Agarwal is a professor of surgery with The University of Chicago in Illinois.

Dr. Bogdana Schmidt

Dr. Bogdana Schmidt, MD, MPH, is a urologic surgeon specializing in urologic oncology at the University of Utah in Salt Lake City, Utah.

Dr. Anne Schuckman

Dr. Anne Schuckman is an associate professor of clinical urology at USC in Los Angeles, California.

Synopsis

The doctors emphasize the importance of having an experienced cytopathologist and discuss the use of different biomarkers and imaging modalities in bladder cancer diagnosis. The conversation delves into risk stratification, patient management strategies, and the evolving role of technology and artificial intelligence in enhancing diagnostic accuracy. The experts also share their perspectives on future advancements and their potential impact on clinical practice.

Timestamps

00:00 - Introduction
04:05 - Surveillance and Follow-Up Strategies
10:10 - Biomarkers in Bladder Cancer
18:02 - Blue Light Cystoscopy and Patient Comfort
30:56 - Risk Assessment and Counseling
42:56 - Future of Bladder Cancer Diagnostics
47:00 - Concluding Thoughts

Resources

CxBladder Study
https://www.sciencedirect.com/science/article/pii/S1078143923000091

Lars Dyrsakjot Study on Tumor Markers
https://pmc.ncbi.nlm.nih.gov/articles/PMC7690647/

The Bridge Trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC10515442/

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast

Techniques & Challenges in Bladder Transplant Surgery with Dr. Nima Nassiri on the BackTable Urology Podcast

Enhancing Care Coordination in Bladder Cancer Treatments with Brynn Moore and Meredith Donahue on the BackTable Urology Podcast

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka on the BackTable Urology Podcast

Non-Muscle Invasive Bladder Cancer: Role of Medical Oncology with Dr. Tyler Stewart on the BackTable Urology Podcast

Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast

Articles

Topics

Non-Muscle Invasive Bladder Cancer (NMIBC) Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.